167 related articles for article (PubMed ID: 34879794)
1. Dysregulation of Lysyl Oxidases Expression in Diabetic Nephropathy and Renal Cell Carcinoma.
Añazco C; Cerro S; Pereira N; Rojas C; Torres Á; Vidal-Beltrán I
Curr Drug Targets; 2021; 22(17):1916-1925. PubMed ID: 34879794
[TBL] [Abstract][Full Text] [Related]
2. Lysyl oxidases expression and histopathological changes of the diabetic rat nephron.
Chen J; Ren J; Loo WTY; Hao L; Wang M
Mol Med Rep; 2018 Feb; 17(2):2431-2441. PubMed ID: 29207131
[TBL] [Abstract][Full Text] [Related]
3. An in situ activity assay for lysyl oxidases.
Wang H; Poe A; Pak L; Nandakumar K; Jandu S; Steppan J; Löser R; Santhanam L
Commun Biol; 2021 Jul; 4(1):840. PubMed ID: 34226627
[TBL] [Abstract][Full Text] [Related]
4. Lysyl oxidase inhibitors attenuate cyclosporin A-induced nephropathy in mouse.
Nguyen LT; Saad S; Shi Y; Wang R; Chou ASY; Gill A; Yao Y; Jarolimek W; Pollock CA
Sci Rep; 2021 Jun; 11(1):12437. PubMed ID: 34127702
[TBL] [Abstract][Full Text] [Related]
5. Lysyl Oxidase-like-2 Cross-links Collagen IV of Glomerular Basement Membrane.
Añazco C; López-Jiménez AJ; Rafi M; Vega-Montoto L; Zhang MZ; Hudson BG; Vanacore RM
J Biol Chem; 2016 Dec; 291(50):25999-26012. PubMed ID: 27770022
[TBL] [Abstract][Full Text] [Related]
6. Perturbations to lysyl oxidase expression broadly influence the transcriptome of lung fibroblasts.
Mižíková I; Palumbo F; Tábi T; Herold S; Vadász I; Mayer K; Seeger W; Morty RE
Physiol Genomics; 2017 Aug; 49(8):416-429. PubMed ID: 28698228
[TBL] [Abstract][Full Text] [Related]
7. Lysyl Oxidase Family Enzymes and Their Role in Tumor Progression.
Liburkin-Dan T; Toledano S; Neufeld G
Int J Mol Sci; 2022 Jun; 23(11):. PubMed ID: 35682926
[TBL] [Abstract][Full Text] [Related]
8. Functions and Mechanisms of Pro-Lysyl Oxidase Processing in Cancers and Eye Pathologies with a Focus on Diabetic Retinopathy.
Trackman PC; Peymanfar Y; Roy S
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563478
[TBL] [Abstract][Full Text] [Related]
9. Lysyl oxidase-like 2 inhibition ameliorates glomerulosclerosis and albuminuria in diabetic nephropathy.
Stangenberg S; Saad S; Schilter HC; Zaky A; Gill A; Pollock CA; Wong MG
Sci Rep; 2018 Jun; 8(1):9423. PubMed ID: 29930330
[TBL] [Abstract][Full Text] [Related]
10. Lysyl Oxidase (LOX) Family Members: Rationale and Their Potential as Therapeutic Targets for Liver Fibrosis.
Chen W; Yang A; Jia J; Popov YV; Schuppan D; You H
Hepatology; 2020 Aug; 72(2):729-741. PubMed ID: 32176358
[TBL] [Abstract][Full Text] [Related]
11. Lysyl oxidases: from enzyme activity to extracellular matrix cross-links.
Vallet SD; Ricard-Blum S
Essays Biochem; 2019 Sep; 63(3):349-364. PubMed ID: 31488698
[TBL] [Abstract][Full Text] [Related]
12. Lysyl oxidases: Emerging biomarkers and therapeutic targets for various diseases.
Yang N; Cao DF; Yin XX; Zhou HH; Mao XY
Biomed Pharmacother; 2020 Nov; 131():110791. PubMed ID: 33152948
[TBL] [Abstract][Full Text] [Related]
13. Extracellular Processing of Lysyl Oxidase-like 2 and Its Effect on Amine Oxidase Activity.
Okada K; Moon HJ; Finney J; Meier A; Mure M
Biochemistry; 2018 Dec; 57(51):6973-6983. PubMed ID: 30499665
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of N-glycosylation by glucosamine hydrochloride inhibits TGF-β1-induced LOXL2 secretion.
Kamiya T; Kadowaki M; Atobe T; Kunieda K; Morimoto K; Hara H
J Cell Biochem; 2023 Jun; 124(6):797-807. PubMed ID: 37062903
[TBL] [Abstract][Full Text] [Related]
15. Crystal structure of human lysyl oxidase-like 2 (hLOXL2) in a precursor state.
Zhang X; Wang Q; Wu J; Wang J; Shi Y; Liu M
Proc Natl Acad Sci U S A; 2018 Apr; 115(15):3828-3833. PubMed ID: 29581294
[TBL] [Abstract][Full Text] [Related]
16. Lysyl oxidase-like 2 (LOXL2)-mediated cross-linking of tropoelastin.
Schmelzer CEH; Heinz A; Troilo H; Lockhart-Cairns MP; Jowitt TA; Marchand MF; Bidault L; Bignon M; Hedtke T; Barret A; McConnell JC; Sherratt MJ; Germain S; Hulmes DJS; Baldock C; Muller L
FASEB J; 2019 Apr; 33(4):5468-5481. PubMed ID: 30676771
[TBL] [Abstract][Full Text] [Related]
17. Evolving roles of lysyl oxidase family in tumorigenesis and cancer therapy.
Ye M; Song Y; Pan S; Chu M; Wang ZW; Zhu X
Pharmacol Ther; 2020 Nov; 215():107633. PubMed ID: 32693113
[TBL] [Abstract][Full Text] [Related]
18. Abnormal deposition of collagen around hepatocytes in Wilson's disease is associated with hepatocyte specific expression of lysyl oxidase and lysyl oxidase like protein-2.
Vadasz Z; Kessler O; Akiri G; Gengrinovitch S; Kagan HM; Baruch Y; Izhak OB; Neufeld G
J Hepatol; 2005 Sep; 43(3):499-507. PubMed ID: 16023247
[TBL] [Abstract][Full Text] [Related]
19. Lysyl oxidases play a causal role in vascular remodeling in clinical and experimental pulmonary arterial hypertension.
Nave AH; Mižíková I; Niess G; Steenbock H; Reichenberger F; Talavera ML; Veit F; Herold S; Mayer K; Vadász I; Weissmann N; Seeger W; Brinckmann J; Morty RE
Arterioscler Thromb Vasc Biol; 2014 Jul; 34(7):1446-58. PubMed ID: 24833797
[TBL] [Abstract][Full Text] [Related]
20. Lysyl oxidases regulate fibrillar collagen remodelling in idiopathic pulmonary fibrosis.
Tjin G; White ES; Faiz A; Sicard D; Tschumperlin DJ; Mahar A; Kable EPW; Burgess JK
Dis Model Mech; 2017 Nov; 10(11):1301-1312. PubMed ID: 29125826
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
